SciVision Biotech Inc. (1786.TW) TAI
Currency In TWD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.26B |
| Enterprise Value | 4.9B |
| P/E Ratio | 16.4 |
| PEG Ratio | 3.16 |
| Price/Sales Ratio | 3.27 |
| Price/Book Ratio | 1.66 |
| Enterprise/Revenue | 3.05 |
| Enterprise/EBITDA | 10.37 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.2 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 886.62M |
| Revenue/Share | 11.98 |
| Gross Profit | 638.39M |
| EBITDA | 270.35M |
| Net Income | 162.34M |
| Diluted EPS | 2.24 |
Balance Sheet
| Total Cash | 905.67M |
| Total Cash/Share | 12.2 |
| Total Debt | 485.61M |
| Total Debt/Equity | 0.27 |
| Current Ratio | 6.46 |
| Book Value Per Share | 24.07 |
Price History
| 52-Week Change | -57.43 |
| 52-Week High | 94.8 |
| 52-Week Low | 39.3 |
| Moving Average 50 Days | 45 |
| Moving Average 200 Days | 58.06 |
Statistics
| Average Volume | 163,052 |
| Shares Outstanding | 72.98M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.91 |
| Trailing Annual Dividend Yield | 4.79 |
| Payout Ratio | 0.8 |
| Last Split Factor | 217:200 |
| Last Split Date | October 04, 2021 |
AD
